Baxter recalls Bendamustine HCl injection vials with missing or peeled labels. This could lead to incorrect dosing if the label is damaged. Affected vials have specific lot numbers and expiration dates.
“Baxter Bendamustine HCl Injection Recall: Missing Labels Risk Peeling.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33209-baxter-bendamustine-hcl-injection-recall-missing-labels-risk-peeling. Based on FDA recall #D-1103-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1103-2023%22&limit=1).
The FDA announced on August 14, 2023, that Baxter Healthcare Corporation is recalling Bendamustine HCl Injection due to missing or peeled labels. The recall affects 13,502 vials distributed nationwide.
How to tell if you have it
Brand: Baxter
Product: Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial
The hazard is missing labeling because customer complaints indicated that labels were partially or completely peeled off the injection vials.
Context
GovInfoNow's records show Baxter Healthcare Corporation has 187 other recalls on record since September 2, 2015. Other recent recalls of similar products include American Regent Levocarnitine Injection Recall (April 16, 2026) and Asclemed Lidocaine HCl Injection Recall (June 8, 2026).
How to tell if you have this one
Check for vials with lot numbers 3A004A, 3A004B (expiring 12/31/2024) or 3B005A (expiring 1/31/2025). The product is a 4mL multiple-dose vial for prescription use.
Brand
Baxter
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Label Condition
Inspect the vial for missing or peeled labels. If labels are damaged, stop using the vial.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the U.S.A.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 16 days after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1103-2023 (August 14, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1103-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.